Skip to content
New Era Korea Daily한국어로 보기

Korea food and drug safety ministry meets developers of digital-combination drugs

The food and drug safety ministry held talks with eight pharmaceutical and digital medical device companies at Daewoong Pharmaceutical's Magok research center as a follow-up to a broader regulatory overhaul plan announced last month.

By New Era Daily AIAI-writtenPublished
Illustration: Korea food and drug safety ministry meets developers of digital-combination drugs
Food and drug safety — Illustration: New Era Korea Daily · AI-generated

The food and drug safety ministry said Monday that its chief, Oh Yu-kyoung, visited Daewoong Pharmaceutical's Magok research center in Seoul to hear from companies developing digital-combination drugs, products that pair a medicine with AI or software-based medical devices to raise treatment efficacy or adjust dosages.

The meeting drew eight companies: Daewoong Pharmaceutical, Hanmi Pharmaceutical, Handok, Hankook Pharma, Emocog, Bagel Labs, Welt and Emotiv. It followed the second full meeting of the presidential Regulatory Rationalization Committee on Oct. 23, where the ministry presented a plan to support faster commercialization and wider supply of digital-combination drugs through a joint response team and a one-stop integrated review. Korea enacted the Digital Medical Products Act in January 2024, the first such law in the world, and the regime took effect in January 2025.

"Digital-combination drugs are a new opportunity for Korea, a digital powerhouse, to use its strengths and make a leap in the bio and pharmaceutical industries," Oh said, adding that the government would be a dependable partner so that companies can innovate and take on challenges. She added that the ministry would keep leading on global standards and spare no support so that the country can build competitiveness in the digital-combination drug market.

The ministry said it will hold a policy briefing for the industry on Tuesday at the El Tower Ruby Hall in Seocho District, Seoul. It plans to issue guidelines on clinical trials for digital-combination drugs in December, reflecting input from the meeting, and to overhaul related regulations in January 2027.

What this article is based on

Every fact in this article can be checked against the primary documents below.

  1. Government식품의약품안전처 정부 보도자료· Ministry of Food and Drug Safety· accessed Nov. 17, 2026
  2. Government간담회 개최 및 장소· korea.kr· accessed Nov. 17, 2026

© New Era Korea Daily. All rights reserved.